We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Death Risk in Noncardiac Surgery Affected by Anemia

By HospiMedica International staff writers
Posted on 18 Oct 2011
Even mild preoperative anemia appears to be independently associated with an increased mortality risk in patients undergoing major noncardiac surgery, according to a new study.

Researchers at the American University of Beirut Medical Center (AUBMC; Lebanon) analyzed data from The American College of Surgeons (ACS) US national surgical quality improvement program database, involving 227,425 patients undergoing major noncardiac surgery in 2008. More...
Data for 30-day mortality and morbidity, demographics, and preoperative and perioperative risk factors were used to assess the adjusted and modified effect of anemia, which was defined as mild, or moderate-to-severe on postoperative outcomes. The data showed that 69,229 (30.44%) of the patients had preoperative anemia.

The results showed that postoperative mortality at 30 days was higher in patients with anemia than in those without anemia; this difference was consistent in mild anemia and moderate-to-severe anemia. Composite postoperative morbidity at 30 days was also higher in patients with anemia than in those without anemia, again consistent in patients with mild anemia and moderate-to-severe anemia. When compared with patients without anemia or a defined risk factor, patients with anemia and most risk factors had a higher risk for 30-day mortality and morbidity than did patients with either anemia or the risk factor alone.

“The detrimental effects of preoperative anemia may be associated with increased risk for major noncardiac morbidity, including respiratory, urinary, wound, septic, and thromboembolic complications,” concluded lead author Khaled Musallam, MD, and colleagues from the department of internal medicine. “A 42% adjusted increase in death rate in such a large sample size means that around 500 extra people could die from even a mild degree of anemia after elective major noncardiac surgery.”

Anemia is a decrease in number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. Because hemoglobin--found inside RBCs-- carries oxygen from the lungs to the tissues, anemia leads to hypoxia in organs. Because all human cells depend on oxygen for survival, varying degrees of anemia can have a wide range of clinical consequences.

Measured by hematocrit concentration, anemia is defined as mild when it was between 29%-39% in men and 29%-36% in women, or moderate-to-severe when it is lower than 29% in both men and women on postoperative outcomes.

Related Links:

American University of Beirut Medical Center




Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.